First-trimester Down syndrome screening: Free β-human chorionic gonadotropin and pregnancy-associated plasma protein A
- 1 February 1996
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 174 (2) , 612-616
- https://doi.org/10.1016/s0002-9378(96)70436-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Maternal serum free beta hCG screening: Results of studies including 480 cases of down syndromePrenatal Diagnosis, 1994
- Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotrophin.BMJ, 1993
- First‐trimester biochemical screening for fetal chromosome abnormalities and neural tube defectsPrenatal Diagnosis, 1993
- Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.BMJ, 1992
- First‐trimester maternal serum human chorionic gonadotrophin as a marker for fetal chromosomal disordersPrenatal Diagnosis, 1992
- Maternal serum Down syndrome screening: Free β-protein is a more effective marker than human chorionic gonadotropinAmerican Journal of Obstetrics and Gynecology, 1990
- First‐trimester maternal serum biochemical indicators in Down syndromePrenatal Diagnosis, 1990
- FIRST-TRIMESTER BIOCHEMICAL SCREENING FOR DOWN SYNDROMEThe Lancet, 1988
- Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalitiesPrenatal Diagnosis, 1987
- An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalitiesAmerican Journal of Obstetrics and Gynecology, 1984